Skip to main content
Top
Published in: Journal of Translational Medicine 1/2012

Open Access 01-12-2012 | Research

The globular heads of the C1q receptor regulate apoptosis in human cervical squamous carcinoma cells via a p53-dependent pathway

Authors: Zheng-lin Chen, Ping-qing Gu, Kangsheng Liu, Ya-juan Su, Ling-juan Gao

Published in: Journal of Translational Medicine | Issue 1/2012

Login to get access

Abstract

Background

The globular heads of the human C1q receptor (gC1qR) localize predominantly to the mitochondrial matrix. gC1qR mediates many biological responses, including growth perturbation, morphological abnormalities and the initiation of apoptosis. The purpose of this study was to investigate the relationship between mitochondrial dysfunction, p53 status and gC1qR expression and the regulation of apoptosis in human cervical squamous carcinoma cells (C33a and SiHa).

Methods

Here, gC1qR expression was examined in human cervical tissues using real-time PCR and Western blot analysis. Apoptotic death of C33a and SiHa cells was assessed by flow cytometric analysis that detected the subG1 population. Mitochondrial function was assessed via ROS generation, the content of cytosolic Ca2+, and the change in mitochondrial membrane potential (Δψm). The viability and migration of C33a and SiHa cells were detected via the water-soluble tetrazolium salt (WST-1) assay and the transwell assay, respectively.

Results

gC1qR expression was decreased in cervical squamous cell carcinoma tissues compared with normal tissues. C33a and SiHa cells transfected with a vector encoding gC1qR displayed mitochondrial dysfunction and apoptosis, which was abrogated by the addition of a mutant form of p53 or p53 small interference RNA (siRNA). Furthermore, upon overexpression of gC1qR, cell viability and migration were significantly enhanced, and the apoptosis of C33a and SiHa cells were decreased when cells were treated with mutant p53 or p53 siRNA.

Conclusions

These data support a mechanism whereby gC1qR induces apoptosis through the mitochondrial and p53-dependent pathways in cervical squamous cell carcinoma.
Appendix
Available only for authorised users
Literature
1.
go back to reference Clare J, Edwards D, Bagnall H, Pearmain P, Lawrence G: The use of cervical screening history data to interpret cervical cancer incidence trends. J Public Health (Oxf). 2008, 30: 171-177. 10.1093/pubmed/fdn008.CrossRef Clare J, Edwards D, Bagnall H, Pearmain P, Lawrence G: The use of cervical screening history data to interpret cervical cancer incidence trends. J Public Health (Oxf). 2008, 30: 171-177. 10.1093/pubmed/fdn008.CrossRef
2.
go back to reference Gao LJ, Guo SY, Cai YQ, Gu PQ, Su YJ, Gong H, Liu Y, Chen C: Cooperation of decay-accelerating factor and membrane cofactor protein in regulating survival of human cervical cancer cells. BMC Cancer. 2009, 9: 384-388. 10.1186/1471-2407-9-384.CrossRefPubMedPubMedCentral Gao LJ, Guo SY, Cai YQ, Gu PQ, Su YJ, Gong H, Liu Y, Chen C: Cooperation of decay-accelerating factor and membrane cofactor protein in regulating survival of human cervical cancer cells. BMC Cancer. 2009, 9: 384-388. 10.1186/1471-2407-9-384.CrossRefPubMedPubMedCentral
3.
go back to reference Patel S, Chiplunkar S: Host immune responses to cervical cancer. Curr Opin Obstet Gynecol. 2009, 21: 54-59. 10.1097/GCO.0b013e32831a9890.CrossRefPubMed Patel S, Chiplunkar S: Host immune responses to cervical cancer. Curr Opin Obstet Gynecol. 2009, 21: 54-59. 10.1097/GCO.0b013e32831a9890.CrossRefPubMed
4.
go back to reference Dedio J, Jahnen-Dechent W, Bachmann M, Muller-Esterl W: The multiligand-binding protein gC1qR, putative C1q receptor, is a mitochondrial protein. J Immunol. 1998, 160: 3534-3542.PubMed Dedio J, Jahnen-Dechent W, Bachmann M, Muller-Esterl W: The multiligand-binding protein gC1qR, putative C1q receptor, is a mitochondrial protein. J Immunol. 1998, 160: 3534-3542.PubMed
5.
go back to reference Rubinstein DB, Stortchevoi A, Boosalis M, Ashfag R, Ghebrehiwet B, Peerschke EI, Calvo F, Guillaume T: Receptor for the globular heads of C1q (gC1q-R; p33; Hyaluronan-binding protein is preferentially expressed by adenocarcinoma cells. Internl Cancer Res. 2004, 110: 741-750. Rubinstein DB, Stortchevoi A, Boosalis M, Ashfag R, Ghebrehiwet B, Peerschke EI, Calvo F, Guillaume T: Receptor for the globular heads of C1q (gC1q-R; p33; Hyaluronan-binding protein is preferentially expressed by adenocarcinoma cells. Internl Cancer Res. 2004, 110: 741-750.
6.
go back to reference Yao ZQ, Waggoner SN, Cruise MW, Hall C, Xie X, Oldach DW, Hahn YS: SOCS1 and SOCS3 are targeted by hepatitis C virus core/gC1qR ligation to inhibit T-cell function. J Virol. 2005, 79: 15417-15429. 10.1128/JVI.79.24.15417-15429.2005.CrossRefPubMedPubMedCentral Yao ZQ, Waggoner SN, Cruise MW, Hall C, Xie X, Oldach DW, Hahn YS: SOCS1 and SOCS3 are targeted by hepatitis C virus core/gC1qR ligation to inhibit T-cell function. J Virol. 2005, 79: 15417-15429. 10.1128/JVI.79.24.15417-15429.2005.CrossRefPubMedPubMedCentral
7.
go back to reference Peerschke EIB, Minta JO, Zhou SZ, Bini A, Gotlieb A, Colman RW, Ghebrehiwet B: Expression of gC1qR/p33 and its major ligands in human atherosclerotic lesions. Mol Immunol. 2004, 41: 759-766. 10.1016/j.molimm.2004.04.020.CrossRefPubMed Peerschke EIB, Minta JO, Zhou SZ, Bini A, Gotlieb A, Colman RW, Ghebrehiwet B: Expression of gC1qR/p33 and its major ligands in human atherosclerotic lesions. Mol Immunol. 2004, 41: 759-766. 10.1016/j.molimm.2004.04.020.CrossRefPubMed
8.
go back to reference Meenakshi J, Anupama SK, Datta K: Constitutive expression of hyaluronan binding protein 1 (HABP1/p32/gC1qR) in normal fibroblast cells perturbs its growth characteristics and induces apoptosis. Biochem Biophys Res Commun. 2003, 300: 686-693. 10.1016/S0006-291X(02)02788-2.CrossRefPubMed Meenakshi J, Anupama SK, Datta K: Constitutive expression of hyaluronan binding protein 1 (HABP1/p32/gC1qR) in normal fibroblast cells perturbs its growth characteristics and induces apoptosis. Biochem Biophys Res Commun. 2003, 300: 686-693. 10.1016/S0006-291X(02)02788-2.CrossRefPubMed
9.
go back to reference Dey R, Moraes CT: Lack of oxidative phosphorylation and low mitochondrial membrane potential decrease susceptibility to apoptosis and do not modulate the protective effect of Bcl-x(L) in osteosarcoma cells. J Biol Chem. 2000, 275: 7087-7094. 10.1074/jbc.275.10.7087.CrossRefPubMed Dey R, Moraes CT: Lack of oxidative phosphorylation and low mitochondrial membrane potential decrease susceptibility to apoptosis and do not modulate the protective effect of Bcl-x(L) in osteosarcoma cells. J Biol Chem. 2000, 275: 7087-7094. 10.1074/jbc.275.10.7087.CrossRefPubMed
10.
11.
go back to reference Gao LJ, Gu PQ, Fan WM, Liu Z, Qiu F, Peng YZ, Guo XR: The role of gC1qR in regulating survival of human papillomavirus 16 oncogene-transfected cervical cancer cells. In J Oncol. 2011, 39: 1265-1272. Gao LJ, Gu PQ, Fan WM, Liu Z, Qiu F, Peng YZ, Guo XR: The role of gC1qR in regulating survival of human papillomavirus 16 oncogene-transfected cervical cancer cells. In J Oncol. 2011, 39: 1265-1272.
12.
go back to reference Peerschke EI, Murphy TK, Ghebrehiwet B: Activation-dependent surface expression of gC1qR/p33 on human blood platelets. Thromb Haemost. 2003, 89: 331-339.PubMed Peerschke EI, Murphy TK, Ghebrehiwet B: Activation-dependent surface expression of gC1qR/p33 on human blood platelets. Thromb Haemost. 2003, 89: 331-339.PubMed
13.
go back to reference Peerschke EI, Ghebrehiwet B: The contribution of gC1qR/p33 in infection and inflammation. Immunobiology. 2007, 212: 333-342. 10.1016/j.imbio.2006.11.011.CrossRefPubMedPubMedCentral Peerschke EI, Ghebrehiwet B: The contribution of gC1qR/p33 in infection and inflammation. Immunobiology. 2007, 212: 333-342. 10.1016/j.imbio.2006.11.011.CrossRefPubMedPubMedCentral
14.
go back to reference Eisen-Vandervelde AL, Waggoner SN, Yao ZQ, Cale EM, Hahn CS, Hahn YS: Hepatitis C virus core selectively suppresses interleukin-12 synthesis in human macrophages by interfering with AP-1 activation. J Biol Chem. 2004, 279: 43479-43486. 10.1074/jbc.M407640200.CrossRefPubMed Eisen-Vandervelde AL, Waggoner SN, Yao ZQ, Cale EM, Hahn CS, Hahn YS: Hepatitis C virus core selectively suppresses interleukin-12 synthesis in human macrophages by interfering with AP-1 activation. J Biol Chem. 2004, 279: 43479-43486. 10.1074/jbc.M407640200.CrossRefPubMed
15.
go back to reference Meenakshi J, Anupama , Goswami SK, Datta K: Constitutive expression of hyaluronan binding protein 1 (HABP1/p32/gC1qR) in normal fibroblast cells perturbs its growth characteristics and induced apoptosis. Biochem Biophys Res Commun. 2003, 300: 686-693. 10.1016/S0006-291X(02)02788-2.CrossRefPubMed Meenakshi J, Anupama , Goswami SK, Datta K: Constitutive expression of hyaluronan binding protein 1 (HABP1/p32/gC1qR) in normal fibroblast cells perturbs its growth characteristics and induced apoptosis. Biochem Biophys Res Commun. 2003, 300: 686-693. 10.1016/S0006-291X(02)02788-2.CrossRefPubMed
16.
go back to reference Kamal A, Datta K: Upregulation of hyaluronan binding protein 1 (HABP1/p32/gC1qR) is associated with Cisplatin induced apoptosis. Apoptosis. 2006, 11: 861-874. 10.1007/s10495-006-5396-4.CrossRefPubMed Kamal A, Datta K: Upregulation of hyaluronan binding protein 1 (HABP1/p32/gC1qR) is associated with Cisplatin induced apoptosis. Apoptosis. 2006, 11: 861-874. 10.1007/s10495-006-5396-4.CrossRefPubMed
17.
go back to reference Vegh Z, Goyarts EC, Rozengarten K, Mazumder A, Ghebrehiwet B: Maturation-dependent expression of C1q binding protein on the cell surface of human monocyte-derived dendritic cells. Int Immunopharmacol. 2003, 3: 39-51. 10.1016/S1567-5769(02)00211-4.CrossRefPubMed Vegh Z, Goyarts EC, Rozengarten K, Mazumder A, Ghebrehiwet B: Maturation-dependent expression of C1q binding protein on the cell surface of human monocyte-derived dendritic cells. Int Immunopharmacol. 2003, 3: 39-51. 10.1016/S1567-5769(02)00211-4.CrossRefPubMed
18.
go back to reference Muta T, Kang D, Kitajima S, Fujiwara T, Hamasaki N: p32 protein, a splicing factor 2-associated protein, is localized in mitochondrial matrix and is functionally important in maintaining oxidative phosphorylation. J Biol Chem. 1997, 272: 24363-24370. 10.1074/jbc.272.39.24363.CrossRefPubMed Muta T, Kang D, Kitajima S, Fujiwara T, Hamasaki N: p32 protein, a splicing factor 2-associated protein, is localized in mitochondrial matrix and is functionally important in maintaining oxidative phosphorylation. J Biol Chem. 1997, 272: 24363-24370. 10.1074/jbc.272.39.24363.CrossRefPubMed
19.
go back to reference Xu L, Xiao N, Liu F, Ren H, Gu J: Inhibition of RIG-I and MDA5-dependent antiviral response by gC1qR at mitochondria. Proc Natl Acad Sci USA. 2009, 106: 1530-1535. 10.1073/pnas.0811029106.CrossRefPubMedPubMedCentral Xu L, Xiao N, Liu F, Ren H, Gu J: Inhibition of RIG-I and MDA5-dependent antiviral response by gC1qR at mitochondria. Proc Natl Acad Sci USA. 2009, 106: 1530-1535. 10.1073/pnas.0811029106.CrossRefPubMedPubMedCentral
20.
go back to reference Chowdhury AR, Ghosh I, Datta K: Excessive reactive oxygen species induces apoptosis in fibroblasts: role of mitochondrially accumulated hyaluronic acid binding protein 1 (HABP1/p32/gC1qR). Exp Cell Res. 2008, 314: 651-667. 10.1016/j.yexcr.2007.10.033.CrossRefPubMed Chowdhury AR, Ghosh I, Datta K: Excessive reactive oxygen species induces apoptosis in fibroblasts: role of mitochondrially accumulated hyaluronic acid binding protein 1 (HABP1/p32/gC1qR). Exp Cell Res. 2008, 314: 651-667. 10.1016/j.yexcr.2007.10.033.CrossRefPubMed
21.
go back to reference Nho KJ, Chun JM, Kim HK: Ethanol extract of Dianthus chinensis L. induces apoptosis in human hepatocellular carcinoma HepG2 cells in vitro. Evid Based Complement Alternat Med. 2012, 201 (2): 573527- Nho KJ, Chun JM, Kim HK: Ethanol extract of Dianthus chinensis L. induces apoptosis in human hepatocellular carcinoma HepG2 cells in vitro. Evid Based Complement Alternat Med. 2012, 201 (2): 573527-
Metadata
Title
The globular heads of the C1q receptor regulate apoptosis in human cervical squamous carcinoma cells via a p53-dependent pathway
Authors
Zheng-lin Chen
Ping-qing Gu
Kangsheng Liu
Ya-juan Su
Ling-juan Gao
Publication date
01-12-2012
Publisher
BioMed Central
Published in
Journal of Translational Medicine / Issue 1/2012
Electronic ISSN: 1479-5876
DOI
https://doi.org/10.1186/1479-5876-10-255

Other articles of this Issue 1/2012

Journal of Translational Medicine 1/2012 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.